Immuneering uses bioinformatics to develop new medicines while also helping large pharmaceutical companies improve their treatments.

Despite the disruption caused by the pandemic, MIT students have carved out meaningful hands-on experiences.

Computational method for screening drug compounds can help predict which ones will work best against tuberculosis or other diseases.

Study finds that compressing cells, and crowding their contents, can coax them to grow and divide.

MIT researchers find blocking the expressions of the genes XPA and MK2 enhances the tumor-shrinking effects of platinum-based chemotherapies in p53-mutated cancers.

New technology cuts cell culture time by half and uses more targeted cell sorting and purification methods.

A CRISPR-based test developed at MIT and the Broad Institute can detect nearly as many cases as the standard Covid-19 diagnostic.

SMART researchers find exposing bacteria to hydrogen sulfide can increase antimicrobial sensitivity in bacteria that do not produce H2S.

Bacteria linked to Crohn’s disease are difficult to grow in the lab, but MIT engineers have found a way.

The experimental drug has shown promise in early-stage clinical trials conducted in Singapore.